Response to rituximab in an anti-muscle-specific receptor tyrosine kinase- and anti-acetylcholine recepto-double-positive myasthenia gravis patient concomitant with follicular dendritic cell sarcoma

Neurosciences (Riyadh). 2016 Jan;21(1):77-8. doi: 10.17712/nsj.2016.1.20150483.

Authors

Jianmeng Wang¹, Xiujuan Wu, Hui Deng, Ye Liu, Hongping Liu, Xueli Fan, Kangding Liu, Jiang Wu, Hong-Liang Zhang

Affiliation

¹ Department of Neurology, the First Hospital of Jilin University, Jilin University, Changchun, China.

No abstract available

Publication types

Case Reports

MeSH terms

Autoantibodies / immunology
Axilla
Dendritic Cell Sarcoma, Follicular / complications
Dendritic Cell Sarcoma, Follicular / pathology*
Female
Humans
Immunologic Factors / therapeutic use*
Lymph Nodes / pathology*
Middle Aged
Myasthenia Gravis / drug therapy*
Myasthenia Gravis / etiology
Myasthenia Gravis / immunology
Neck
Receptor Protein-Tyrosine Kinases / immunology
Receptors, Cholinergic / immunology
Rituximab / therapeutic use*
Treatment Outcome

Substances

Autoantibodies
Immunologic Factors
Receptors, Cholinergic
Rituximab
MUSK protein, human
Receptor Protein-Tyrosine Kinases